Summary: Cellarity adds CLY-124 Sickle Cell program

Why It Matters: The company has moved from talking about general events to highlighting a specific drug candidate. This shows they are progressing from a broad technology platform to a focused clinical pipeline.

What Changed:

• Replaced "Symposium" links with "CLY-124 Sickle Cell" in the main navigation.
• Added a new "Learn More" call to action specifically for the CLY-124 program.
• Updated the footer navigation to include the Sickle Cell program.